Washington Trust’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-975
Closed -$21.3K 967
2022
Q4
$21.3K Hold
975
﹤0.01% 543
2022
Q3
$24K Hold
975
﹤0.01% 518
2022
Q2
$26K Hold
975
﹤0.01% 504
2022
Q1
$38K Hold
975
﹤0.01% 471
2021
Q4
$45K Hold
975
﹤0.01% 455
2021
Q3
$46K Hold
975
﹤0.01% 538
2021
Q2
$45K Hold
975
﹤0.01% 547
2021
Q1
$43K Hold
975
﹤0.01% 534
2020
Q4
$40K Hold
975
﹤0.01% 533
2020
Q3
$36K Hold
975
﹤0.01% 506
2020
Q2
$33K Hold
975
﹤0.01% 465
2020
Q1
$27K Buy
+975
New +$32.5K ﹤0.01% 490

Other funds holding FFTY

Washington Trust's FFTY Position: Q1 2023 in Review

Washington Trust sold out of CapForce IBD 50 ETF (FFTY) in Q1 2023, closing a stake of 975 shares — an estimated $21.3K sold.

Washington Trust first reported a position in FFTY in Q1 2020 and held it in 12 quarters. The position peaked at $46K in Q3 2021. 47 funds tracked by Wall St. Rank hold FFTY as of Q1 2023.

  • Washington Trust reported no remaining CapForce IBD 50 ETF position as of Q1 2023 after selling out during the quarter.
  • Washington Trust sold 975 CapForce IBD 50 ETF shares in Q1 2023, an estimated $21.3K.
  • Washington Trust first reported a position in CapForce IBD 50 ETF in Q1 2020 and held it in 12 quarters.
  • Washington Trust's CapForce IBD 50 ETF position peaked at $46K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2023.

Based on Washington Trust's 13F filing for Q1 2023, filed 4 May 2023.